Leerink Partners Starts IDEXX Laboratories (IDXX) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St set for higher open as Anthropic's IPO filing sharpens AI focus
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $558.28 -0.37%
Rating Summary:
13 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 40
Rating Summary:
13 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 40
Join SI Premium – FREE
Leerink Partners analyst Daniel Clark initiates coverage on IDEXX Laboratories (NASDAQ: IDXX) with a Outperform rating and a price target of $500.00.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $421.75 yesterday.
You May Also Be Interested In
- Monness, Crespi, Hardt Starts Dave Inc (DAVE) at Neutral
- Lucid Capital Markets Starts Terrestrial Energy Inc. (IMSR) at Buy, PT $10
- Maxim Group Starts Prenetics (PRE) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
